Skip to main content
. 2017 Apr 12;17:263. doi: 10.1186/s12885-017-3272-y

Fig. 1.

Fig. 1

Flow diagram of patient selection. The flow diagram illustrating the inclusion process of the patients with lung adenocarcinoma into the study. Three hundred and four patients were included into serum analysis and 172 patients were included into genomic analysis, with 122 patients included into both analysis